Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 110, Issue 4, 2010, Pages 509-516

  Fleisher, Kenneth E ^a   Welch, Garrett ^a   Kottal, Shailesh ^a   Craig, Ronald G ^a   Saxena, Deepak ^a   Glickman, Robert S ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ALVEOLAR BONE LOSS; ARTICLE; BLOOD; BONE NECROSIS; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; HUMAN; JAW DISEASE; METHODOLOGY; PATHOLOGY; PERIODONTAL LIGAMENT; PREDICTIVE VALUE; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; TOOTH EXTRACTION; TOOTH RADIOGRAPHY;

ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COLLAGEN TYPE I; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS; PEPTIDES; PERIODONTAL LIGAMENT; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, DENTAL; RETROSPECTIVE STUDIES; RISK FACTORS; TOOTH EXTRACTION;

EID: 77957120787     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.04.023     Document Type: Article

References (84)

1. R. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
2. J. Berenson Recommendations for zoledronic acid treatment of patients with bone metastases Oncologist 10 2005 52 62
3. R. Coleman Risks and benefits of bisphosphonates Br J Cancer 98 2008 1736 1740
4. P. Delmas Treatment of postmenopausal osteoporosis Lancet 359 2002 2018 2026
5. S. Ruggiero, J. Gralow, R. Marx, A. Hoff, M. Schubert, and J. Huryn Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer J Oncol Pract 2 2006 7 14
6. R. Rizzoli, N. Burlet, D. Cahall, P. Delmas, E. Eriksen, and D. Felsenberg Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis Bone 42 2008 841 847
7. S. Ruggiero, T. Dodson, L. Assael, R. Landesberg, R. Marx, and B. Mehrotra American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws2009 update J Oral Maxillofac Surg 67 2009 2 12
8. M. Markiewicz, J. Margarone, J. Campbell, and A. Aguirre Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge J Am Dent Assoc 136 2005 1669 1674
9. R. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567 1575
10. M. Melo, and G. Obeid Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy J Am Dent Assoc 136 2005 1675 1681
11. S. Otto, S. Hafner, and K. Grotz The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw J Oral Maxillofac Surg 67 2009 589 592
12. H. Mawardi, N. Treister, and P. Richardson Sinus tractsan early sign of bisphosphonate-associated osteoneonecrosis of the jaws? J Oral Maxillofac Surg 67 2009 593 601
13. T. Van den Wyngaert, M. Huizing, and J. Vermorken Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Ann Oncol 17 2006 1197 1204
14. J. Fantasia Bisphosphonateswhat the dentist needs to know: practical considerations J Oral Maxillofac Surg 67 2009 53 60
15. N. Treister, P. Richardson, R. Schlossman, K. Miller, and S. Woo Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 2008 e1 e4
16. S. Khosla, D. Burr, J. Cauley, D. Dempster, P. Ebeling, and D. Felsenberg Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479 1491
17. C. Migliorati, J. Casiglia, J. Epstein, P. Jacobsen, M. Siegel, and S. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine Position Paper J Am Dent Assoc 136 2005 1658 1668
18. K. Groetz, and B. Al-Nawas Persisting alveolar socketsa radiologic symptom of BP-ONJ? J Oral Maxillofac Surg 64 2006 1571 1572
19. K. Zervas, E. Verrou, Z. Teleioudis, K. Vahtsevanos, A. Banti, and D. Mihou Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single center experience in 303 patients Br J Haematol 134 2006 620 623
20. A. Zavras, and S. Zhu Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis? J Oral Maxillofac Surg 64 2006 917 923
21. A. Hoff, B. Toth, K. Altundag, V. Guarneri, A. Adamus, and A. Nooka Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy [abstract] J Clin Oncol 24 18S 2006 8528
22. A. Bamias, E. Kastritis, C. Bamia, L. Moulopoulos, I. Melakopoulos, and G. Bozas Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 2005 8580 8587
23. B. Durie, M. Katz, and J. Crowley Osteonecrosis of the jaw and bisphosphonates N Engl J Med 353 2005 99 102
24. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
25. S. Christgau, O. Bitsch-Jensen, N. Hanover Bjarnason, E. Gamwell Henriksen, P. Qvist, and P. Alexandersen Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy Bone 26 2000 505 511
26. F. Singer, and D. Eyre Using biochemical markers of bone turnover in clnical practice Cleve Clin J Med 75 2008 739 750
27. J. Souberbielle, C. Cormier, and C. Kindermans Bone markers in clinical practice Curr Opin Rheumatol 11 1999 312 319
28. R. Marx, J. Cillo, and J. Ulloa Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2007 2397 2410
29. F. Bertoldo, D. Santini, and V. Lo Cascio Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle Nat Clin Pract Oncol 4 2007 711 721
30. R. Gliklich, and J. Wilson Epidemiology of bisphosphonate-related osteonecrosis of the jaws: The utility of a national registry J Oral Maxillofac Surg 67 2009 71 74
31. C. Van Poznak, and B. Ward Osteonecrosis of the jaw Curr Opin Orthop 17 2006 462 468
32. S. Baim, and P. Miller Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw J Bone Miner Res 24 2009 561 574
33. K. Fleisher, S. Doty, S. Kottal, J. Phelan, R. Norman, and R. Glickman Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note J Oral Maxillofac Surg 66 2008 2646 2653
34. O. Schei, J. Waerhaug, A. Lovdal, and A. Arno Alveolar bone loss as related to oral hygiene and age J Periodontol 30 1959 7 16
35. M. Cavalcanti, A. Ruprecht, W. Johnson, T. Southard, and J. Jakobsen The contribution of trabecular bone to the visibility of the lamina dura: an in vitro radiographic study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 2002 118 122
36. L. Matson, B. Sjodin, and H. Bloomquist Periodontal health in adapted children of Asian origin living in Sweden Swed Dent J 21 1997 177 184
37. F. Mercado, R. Marshall, A. Klestov, and P. Bartold Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 27 2000 267 272
38. B. Hansen, P. Gjermo, and K. Bergwitw-Larsen Periodontal bone loss in 15-year old Norwegians J Clin Periodontol 11 1984 125 131
39. B. Hansen, P. Gjermo, H. Bellini, K. Ihanamaki, and L. Saxen Prevalence of radiographic bone loss in young adults, a multinational study Int Dent J 45 1995 54 61
40. H. Selikowitz, A. Sheiham, D. Albert, and G. Williams Retrospective longitudinal study of the rate of alveolar bone loss in humans using bitewing radiographs J Clin Periodontol 8 1981 431 438
41. K. Eaton, and A. Woodman Evaluation of simple periodontal screening technique currently used in the UK armed forces Community Dent Oral Epidemiol 17 1989 190 195
42. L. Shapira, E. Tarazi, L. Rosen, and E. Bimstein The relationship between alveolar bone height and age in the primary dentition: a retrospective longitudinal radiographic study J Clin Peirodontol 22 1995 408 412
43. A. Looker, D. Bauer, Cr. Chesnut, A. Looker, D. Bauer, and C. Chesnut Clinical use of biochemical markers of bone remodeling: current status and future directions Osteoporos Int 11 2000 467 480
44. H. Rosen, A. Moses, J. Garber, I. Iloputaife, D. Ross, and S. Lee Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy Calcif Tissue Int 66 2000 100 103
45. S. Robins Collagen turnover in bone diseases Curr Opin Clin Nutr Metab Care 6 2003 65 71
46. J. Brown, R. Cook, P. Major, A. Lipton, F. Saad, and M. Smith Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors J Natl Cancer Inst 97 2005 59 69
47. P. Garnero, and P. Delmas Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone markers Curr Opin Rheumatol 16 2004 428 434
48. E. Terpos, M. Politou, and A. Rahemtulla The role of markers of bone remodeling in multiple myeloma Blood Rev 19 2005 125 142
49. A. Lipton, L. Costa, S. Ali, and L. Demers Use of markers of bone turnover for monitoring bone metastases and the response to therapy Sem Oncol 28 4 Suppl 11 2001 54 59
50. R. Hannon, and R. Eastell Preanalytical variability of biochemical markers of bone turnover Osteoporos Int 11 Suppl 6 2000 S30 S44
51. S. Glover, P. Garnero, K. Naylor, A. Rogers, and R. Eastell Establishing a reference range for bone turnover markers in young, healthy women Bone 42 2008 623 630
52. J. Clowes, R. Hannon, T. Yap, N. Hoyle, A. Blumsohn, and R. Eastell Effect of feeding on bone turnover markers and its impact on biological variability of measurements Bone 30 2002 886 890
53. R. Kunchur, A. Need, T. Hughes, and A. Goss Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 1167 1173
54. S. Lehrer, A. Montazem, L. Ramanathan, M. Pessin-Minsley, J. Pfail, and R. Stock Normal serum bone markers in bisphosphonate-induced osteoncrosis of the jaws Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 2008 389 391
55. C. Berger, A. Kroner, K. Kristen, M. Minai-Pour, T. Leitha, and A. Engel Spontaneous Osteonecrosis of the knee: biochemical markers of bone turnover and pathohistology Osteoarthritis Cartilage 13 2005 716 721
56. S. Koka Osteonecrosis of the jaw and biomarkers: what do we tell our patients? Int J Oral Maxillofac Implants 23 2008 179 180
57. B. Edwards, and C. Migliorati Osteoporosis and its implications for dental patients J Am Dent Assoc 139 2008 545 552
58. C. Krueger, P. West, M. Sargent, A. Lodolce, and A. Pickard Bisphosphonate-induced osteonecrosis of the jaw Ann Pharmacother 41 2007 276 284
59. M. Farrugia, D. Summerlin, E. Krowiak, T. Huntley, S. Freeman, and R. Borrowdale Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 2006 115 120
60. S. White, and M. Pharoah Oral radiology: principles and interpretation 5th ed. 2009 Mosby Oxford
61. A. Nanci, and D. Bosshardt Structure of periodontal tissues in health and disease Periodontol 40 2000 11 28
62. M. Cavalcanti, A. Ruprecht, W. Johnson, T. Southard, and J. Jakobsen The contribution of trabecular bone to the visability of the lamina dura: an in vitro radiographic study Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 2002 118 122
63. Y. Ren, J. Maltha, L. Stokroos, R. Liem, and A. Kuijpers-Jagtman Age-related changes of periodontal ligament surface areas during force application Angle Ortho 78 2008 1000 1005
64. P. Sedghizadeh, S. Kumar, A. Gorur, C. Schaudinn, C. Shuler, and J. Costerton Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy J Oral Maxillofac Surg 66 2008 767 775
65. M. Kos, and K. Luczak Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonization Bioscience Hypotheses 2 2009 34 36
66. F. Abraham, D. Saxena, M. Dalvi, A. Farooki, M. Fornier, and C. Estilo Molecular analysis of bacteria associated with osteonecrosis of the jaw J Dent Res (Spec Iss A) 88 2010 3441
67. C. Wong, X. Wei, S. Pushalkar, Y. Li, M. Fornier, and A. Farooki Evaluating bone microbiota in bisphosphonate related osteonecrosis of the jaw J Dent Res (Spec Iss A) 89 2010 578
68. G. Favia, G. Pilolli, and E. Maiorano Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy Bone 45 2009 506-413
69. J. Epstein, and P. Stevenson-Moore Periodontal disease and periodontal management in patients with cancer Oral Oncol 37 2001 613 619
70. R. Garcia, M. Henshaw, and E. Krall Relationship between periodontal disease and systemic health Periodontol 25 2000 21 36
71. E. Krall, R. Garcia, and B. Dawson-Hughes Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine Calcif Tissue Int 59 1996 433 437
72. S. Ji, J. Hyun, E. Park, B.-L. Lee, K.-K. Kim, and Y. Choi Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils J Periodont Res 42 2007 410 419
73. I. Brynolf A histological and roentgenological study of the periapical region of upper incisors Odont Revy 18 Suppl 11 1967 1 97
74. L. Tronstad, F. Barnett, K. Riso, and J. Slots Extraradicular endodontic infections Endod Dent Traumatol 3 1987 86 90
75. A. Bystrom, and G. Sundqvist Bacterial evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy Scand J Dent Res 89 1981 321 328
76. K. Safavi Root end filling Oral Maxillofac Surg Clin North Am 14 2002 173 177
77. T. Green, R. Walton, J. Taylor, and P. Merrell Radiographic and histologic periapical findings of root canal treated teeth in cadaver Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 1997 707 711
78. J. Pratten, A. Smith, and M. Wilson Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine J Antimicrob Chemo 42 1998 453 459
79. L. Sweeney, J. Dave, P. Chambers, and J. Heritage Antibiotic resistance in general dental practicea cause for concern? J Antimicrob Chemo 53 2004 567 576
80. M. Quirynen, W. Teughels, M. DeSoete, and D. van Steenberghe Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbial aspects Periodontol 28 2000 72 90
81. A. Hoff, B. Toth, K. Altundag, M. Johnson, C. Warneke, and M. Hu Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Min Res 23 2008 826 836
82. F. Pires, A. Miranda, E. Cardoso, A. Cardoso, E. Fregnani, and C. Pereira Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy Oral Dis 11 2005 365 369
83. I. Reid Osteonecrosis of the jawwho gets it, and why? Bone 44 2009 4 10
84. G. Sanna, L. Preda, R. Bruschini, M. Rocca, S. Ferretti, and L. Adamoli Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer Ann Oncol 17 2006 1512 1516